Hydrogenotrophic Methanogen Bioaugmentation for Anaerobic Digester Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Anaerobic digester systems often experience disruptions due to organic overload, leading to prolonged recovery times and reduced methane production, with existing methods lacking effective solutions for rapid recovery and performance enhancement.
Innovation Solution
The introduction of a culture comprising hydrogenotrophic methanogens, specifically from the orders Methanomicrobales or Methanobacteriales, such as Methanospirillum hungatei, Methanobacterium beijingense, or Methanolinea tarda, which are added to the digester system to enhance methane production and reduce propionic acid and chemical oxygen demand (COD) levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If anaerobic digester systems operate under organic overload conditions, then methane production is reduced and process stability deteriorates, but recovery time is prolonged
Solution Approach 1:
The patent applies preliminary action by pre-adapting methanogenic cultures to oxygen exposure before introducing them to the upset digester. This pre-adaptation process creates cultures that are already resistant to oxygen toxicity, enabling them to immediately begin restoring methane production without being inhibited by residual oxygen or rapid fluctuations in digester conditions during the recovery phase.
Solution Approach 2:
The patent implements parameter changes by modifying the physical and biological state of the methanogenic cultures through controlled oxygen exposure. This changes the cultures' tolerance parameters, allowing them to withstand conditions that would normally inhibit methanogenesis during digester upset and recovery, thereby accelerating the return to productive operation.
2Productivity
If traditional bioaugmentation cultures are used, then methane production may be enhanced, but oxygen toxicity tolerance is insufficient leading to culture death
Solution Approach 1:
The patent applies preliminary anti-action by exposing methanogenic cultures to oxygen before they encounter it in the upset digester environment. This pre-exposure creates a counteracting resistance to oxygen toxicity, allowing the cultures to survive and thrive in conditions that would normally be lethal to conventional methanogens. The cultures are essentially pre-vaccinated against oxygen damage.
3Ease of manufacture
If starter culture is obtained from nearby operating digesters, then inoculation is simple and rapid, but the microbial community structure is unknown and may not be optimal
Solution Approach 1:
The patent applies local quality by creating a specialized, locally-adapted culture with specific properties (oxygen tolerance) that are tailored to the needs of upset digesters. Rather than using a generic starter culture from any digester, the method produces a culture with customized characteristics suited for recovery conditions, while still maintaining the simplicity of local production through enrichment of readily available methanogens.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces recovery time and increases methane production by effectively managing propionic acid and COD levels, improving the overall performance and stability of anaerobic digester systems.
Implementation Method 1
Many euryarchaeotal microorganisms can use hydrogen and carbon dioxide to produce methane
Implementation Method 2
select microorganisms are contacted with the waste and convert it to biogas that contains methane
Implementation Method 3
efficient metabolism of hydrogen (H2) and propionic acid is required
Data Source
AI summary
Disclosed herein are methods for improving performance of an anaerobic digester system. The methods typically include adding a culture comprising hydrogenotrophic methanogens to the system, otherwise referred to as bioaugmentation.